PMID- 31297262 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 2067-0656 (Print) IS - 2069-4032 (Electronic) VI - 45 IP - 1 DP - 2019 Jan-Mar TI - The Link Between Bone Osteocalcin and Energy Metabolism in a Group of Postmenopausal Women. PG - 47-51 LID - 10.12865/CHSJ.45.01.06 [doi] AB - There is a dual relationship between bone and tissues involved in energy metabolism (fat tissue and beta-pancreatic cells). Thus, bone remodeling is an energy consuming process, but osteocalcin, the main on-collagenic protein, synthesized by osteoblas during bone formation exerts a number of biological effects on beta-pancreatic and adipose cells. With this data, we wanted to see if the presence of a chronic metabolic disorder such as type 2 diabetes mellitus (T2DM) influence this complex dual relationship. For this, we conducted a cross-sectional study to evaluate the relation between osteocalcin and energetic metabolism in a group of 146 postmenopausal womens with and without T2DM at CI Parhon National Institute of Endocrinology, Bucharest. Clinical, metabolic and hormonal parameters were evaluated. For statistical analysis we used Student t-test and the Spearman correlation (statistical significance: p <0.05). Results: 63 patients with T2DM (63.88+/-8.56 years) and 83 women in the control group (60.21+/-8.77 years) were included. Diabetic women showed a lower level of serum total osteocalcin (p<0.05) HDL-cholesterol (p=0.02), and 25-hydroxyvitamin D (25(OH)D). The body mass index (BMI), glycemic metabolism parameters and triglyceride levels (p<0.05) were higher in this group. We found correlations between osteocalcin and metabolic elements: negative with BMI (r=-0.329, p<0.05), glycated hemoglobin (HbA1c) (r=-0.398, p<0.05), and serum triglycerides (r=-0.329, p<0.05) respectively positive with HDL-cholesterol (r=0.279, p=0.001) for the entire group of patients. Conclusions: Our study indicated the presence of significant correlations between serum osteocalcin and glycemic and lipid metabolism parameters, independent of the presence of diabetes. FAU - Dumitru, N AU - Dumitru N AD - C.I. Parhon National Institute of Endocrinology, Bucharest, Romania. AD - "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. FAU - Carsote, M AU - Carsote M AD - C.I. Parhon National Institute of Endocrinology, Bucharest, Romania. AD - "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. FAU - Cocolos, A AU - Cocolos A AD - C.I. Parhon National Institute of Endocrinology, Bucharest, Romania. AD - "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. FAU - Petrova, E AU - Petrova E AD - C.I. Parhon National Institute of Endocrinology, Bucharest, Romania. AD - "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. FAU - Olaru, M AU - Olaru M AD - C.I. Parhon National Institute of Endocrinology, Bucharest, Romania. FAU - Dumitrache, C AU - Dumitrache C AD - "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. FAU - Ghemigian, A AU - Ghemigian A AD - C.I. Parhon National Institute of Endocrinology, Bucharest, Romania. AD - "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. LA - eng PT - Case Reports DEP - 20190331 PL - Romania TA - Curr Health Sci J JT - Current health sciences journal JID - 101597164 PMC - PMC6592666 OTO - NOTNLM OT - Bone turnover OT - energy metabolism OT - insulin OT - osteoblast OT - osteocalcin EDAT- 2019/07/13 06:00 MHDA- 2019/07/13 06:01 PMCR- 2019/01/01 CRDT- 2019/07/13 06:00 PHST- 2019/02/05 00:00 [received] PHST- 2019/03/16 00:00 [accepted] PHST- 2019/07/13 06:00 [entrez] PHST- 2019/07/13 06:00 [pubmed] PHST- 2019/07/13 06:01 [medline] PHST- 2019/01/01 00:00 [pmc-release] AID - 2019.01.06 [pii] AID - 10.12865/CHSJ.45.01.06 [doi] PST - ppublish SO - Curr Health Sci J. 2019 Jan-Mar;45(1):47-51. doi: 10.12865/CHSJ.45.01.06. Epub 2019 Mar 31.